Literature DB >> 16953442

Structure-based 3D-QSAR studies on thiazoles as 5-HT3 receptor antagonists.

Li-Ping Zhu1, De-Yong Ye, Yun Tang.   

Abstract

Structure-based 3D-QSAR studies were performed on 20 thiazoles against their binding affinities to the 5-HT(3) receptor with comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA). The thiazoles were initially docked into the binding pocket of a human 5-HT(3A) receptor homology model, constructed on the basis of the crystal structure of the snail acetylcholine binding protein (AChBP), using the GOLD program. The docked conformations were then extracted and used to build the 3D-QSAR models, with cross-validated r2omega values 0.785 and 0.744 for CoMFA and CoMSIA, respectively. An additional five molecules were used to validate the models further, giving satisfactory predictive r2 values of 0.582 and 0.804 for CoMFA and CoMSIA, respectively. The results would be helpful for the discovery of new potent and selective 5-HT(3) receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16953442     DOI: 10.1007/s00894-006-0131-1

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  18 in total

1.  Binding interactions of antagonists with 5-hydroxytryptamine3A receptor models.

Authors:  Gábor Maksay; Zsolt Bikádi; Miklós Simonyi
Journal:  J Recept Signal Transduct Res       Date:  2003       Impact factor: 2.092

2.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

Authors:  R D Cramer; D E Patterson; J D Bunce
Journal:  J Am Chem Soc       Date:  1988-08-01       Impact factor: 15.419

3.  Development and validation of a genetic algorithm for flexible docking.

Authors:  G Jones; P Willett; R C Glen; A R Leach; R Taylor
Journal:  J Mol Biol       Date:  1997-04-04       Impact factor: 5.469

4.  Conformation-activity relationship study of 5-HT3 receptor antagonists and a definition of a model for this receptor site.

Authors:  M F Hibert; R Hoffmann; R C Miller; A A Carr
Journal:  J Med Chem       Date:  1990-06       Impact factor: 7.446

5.  Ultrastructure of the 5-hydroxytryptamine3 receptor.

Authors:  F G Boess; R Beroukhim; I L Martin
Journal:  J Neurochem       Date:  1995-03       Impact factor: 5.372

6.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation.

Authors:  G Jones; P Willett; R C Glen
Journal:  J Mol Biol       Date:  1995-01-06       Impact factor: 5.469

7.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

Review 8.  Role of 5-hydroxytryptamine3 (5-HT3) antagonists in the prevention of emesis caused by anticancer therapy.

Authors:  F Karim; S C Roerig; D Saphier
Journal:  Biochem Pharmacol       Date:  1996-09-13       Impact factor: 5.858

9.  Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.

Authors:  T Rosen; A A Nagel; J P Rizzi; J L Ives; J B Daffeh; A H Ganong; K Guarino; J Heym; S McLean; J T Nowakowski
Journal:  J Med Chem       Date:  1990-10       Impact factor: 7.446

Review 10.  Spectrum of use and tolerability of 5-HT3 receptor antagonists.

Authors:  U Haus; M Späth; L Färber
Journal:  Scand J Rheumatol Suppl       Date:  2004
View more
  1 in total

1.  Synthesis, Characterization and Molecular Docking of Novel Bioactive Thiazolyl-Thiazole Derivatives as Promising Cytotoxic Antitumor Drug.

Authors:  Sobhi M Gomha; Taher A Salaheldin; Huwaida M E Hassaneen; Hassan M Abdel-Aziz; Mohammed A Khedr
Journal:  Molecules       Date:  2015-12-22       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.